Evidence map›Paper›PMID 20051129›Full record

ArticleRespiratory research2010

Differential expression of Toll-like receptors on human alveolar macrophages and autologous peripheral monocytes.

Esmeralda Juarez, Carlos Nuñez, Eduardo Sada, Jerrold J Ellner, Stephan K Schwander, Martha Torres

Open access · goldAbstract readComparative Study
In one paragraph

Article in Respiratory research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 138 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Sympathetic regulation of the host immune response to bacterial sepsis.Clinical science (London, England : 1979) · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Esmeralda JuarezCenter for Emerging & Reemerging Pathogens, University of Medicine and Dentistry New Jersey S Orange Ave, Newark 07103, USA.
Carlos Nuñez
Eduardo Sada
Jerrold J Ellner
Stephan K Schwander
Martha Torres
Instituto Nacional de Enfermedades Respiratorias · MXBoston Medical Center · USEnvironmental and Occupational Health Sciences Institute · US

Funding

Air Pollution Particle Effects on Human Antimycobacterial ImmunityR01ES020382 · NIEHS · UNIV OF MED/DENT NJ-SCH OF PUBLIC HEALTH · PI STEPHAN K SCHWANDER · 2012 to 2026
$5.3M
EXPRESSION OF TUBERCULOSIS IN THE LUNGR01HL051630 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI ELLNER, JERROLD J. · 1993 to 2004
$2.2M
Diesel Exhaust Particle Effects on Human Immunity to Mycobacterium tuberculosisR21ES016928 · NIEHS · UNIV OF MED/DENT NJ-SCH OF PUBLIC HEALTH · PI SCHWANDER, STEPHAN K · 2008 to 2010
$439k
NHLBI NIH HHS 2R01HL51630NIEHS NIH HHS R01 ES020382NIEHS NIH HHS R21ES016928-02
6 · The paper itself

Abstract

backgroundToll-like receptors (TLRs) are critical components in the regulation of pulmonary immune responses and the recognition of respiratory pathogens such as Mycobacterium Tuberculosis (M.tb). Through examination of human alveolar macrophages this study attempts to better define the expression profiles of TLR2, TLR4 and TLR9 in the human lung compartment which are as yet still poorly defined.

methodsSixteen healthy subjects underwent venipuncture, and eleven subjects underwent additional bronchoalveolar lavage to obtain peripheral blood mononuclear and bronchoalveolar cells, respectively. Surface and intracellular expression of TLRs was assessed by fluorescence-activated cell sorting and qRT-PCR. Cells were stimulated with TLR-specific ligands and cytokine production assessed by ELISA and cytokine bead array.

resultsSurface expression of TLR2 was significantly lower on alveolar macrophages than on blood monocytes (1.2 +/- 0.4% vs. 57 +/- 11.1%, relative mean fluorescence intensity [rMFI]: 0.9 +/- 0.1 vs. 3.2 +/- 0.1, p < 0.05). The proportion of TLR4 and TLR9-expressing cells and the rMFIs of TLR4 were comparable between alveolar macrophages and monocytes. The surface expression of TLR9 however, was higher on alveolar macrophages than on monocytes (rMFI, 218.4 +/- 187.3 vs. 4.4 +/- 1.4, p < 0.05) while the intracellular expression of the receptor and the proportion of TLR9 positive cells were similar in both cell types. TLR2, TLR4 and TLR9 mRNA expression was lower in bronchoalveolar cells than in monocytes.Pam3Cys, LPS, and M.tb DNA upregulated TLR2, TLR4 and TLR9 mRNA in both, bronchoalveolar cells and monocytes. Corresponding with the reduced surface and mRNA expression of TLR2, Pam3Cys induced lower production of TNF-alpha, IL-1beta and IL-6 in bronchoalveolar cells than in monocytes. Despite comparable expression of TLR4 on both cell types, LPS induced higher levels of IL-10 in monocytes than in alveolar macrophages. M.tb DNA, the ligand for TLR9, induced similar levels of cytokines in both cell types.

conclusionThe TLR expression profile of autologous human alveolar macrophages and monocytes is not identical, therefore perhaps contributing to compartmentalized immune responses in the lungs and systemically. These dissimilarities may have important implications for the design and efficacy evaluation of vaccines with TLR-stimulating adjuvants that target the respiratory tract.

Indexed as

AdultCells, CulturedFemaleGene ExpressionHumansLeukocytes, MononuclearLungMacrophagesMalePulmonary AlveoliToll-Like ReceptorsTuberculosisToll-Like Receptors

Identifiers

PMID20051129
PMCPMC2817655
OpenAlexW2131700917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.